Porosome Therapeutics, Inc.

Biotech Boston, MA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Boston, MA
Street
One Boston Place, Ste 2631
Zip
02108

Offering

Total offering
—
Amount sold
$3.6M
First sale
Sep 8, 2023
Min investment
$50k
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
7

How this filing compares

Other Massachusetts filings this week: Apnimed, Inc., BCV Emerge Fund V, L.P., LONG POINT INVESTORS, L.P., Neosoma, Inc., TA Realty Digital Real Estate Fund I, L.P.

Leadership

Guillermo Marmol — Executive Officer

Filing details

Porosome Therapeutics, Inc. filed a Form D with the SEC on March 24, 2026.

Other newest Biotech companies

Other newest companies in Massachusetts